
Men receiving the radioactive "seeds" were more likely to be cancer-free five to nine years later. ...continue reading Brachytherapy combination improves PSA-free survival for patients with higher-risk localized prostate cancer, trial finds
PSA Rising Prostate Cancer News
Evidence-Based, Patient-Centered
Men receiving the radioactive "seeds" were more likely to be cancer-free five to nine years later. ...continue reading Brachytherapy combination improves PSA-free survival for patients with higher-risk localized prostate cancer, trial finds
January 7, 2006. A new radiation therapy for prostate cancer -- Cesium-131 brachytherapy -- has fewer side effects than other treatments. NewYork-Presbyterian Hospital/Weill Cornell Medical Center is the only hospital in the Northeast to offer the new therapy.
...continue reading Cesium-131 Brachytherapy for Prostate Cancer Has Fewer Side Effects